InvaGen Pharmaceuticals Inc

Cipla subsidiary gets termination notice on $215 million deal with US firm Avenue Therapeutics

Healthcare

03 November, 2021

Cipla subsidiary gets termination notice on $215 million deal with US firm Avenue Therapeutics

Indian drugmaker Cipla Ltd said its subsidiary InvaGen Pharmaceuticals has received a notice of termination on a three year old ......

Joseph Rai

Cipla to acquire US-based speciality drugmaker Avenue Therapeutics

Healthcare

13 November, 2018

Cipla to acquire US-based speciality drugmaker Avenue Therapeutics

Indian drugmaker Cipla Ltd said Tuesday it has signed pacts to acquire Nasdaq-listed speciality pharmaceutical company Avenue Therapeutics Inc. for ......

Joseph Rai

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News

FOLLOW

InvaGen Pharmaceuticals Inc

Healthcare

Cipla subsidiary gets termination notice on $215 million deal with US firm Avenue Therapeutics

Healthcare

Cipla to acquire US-based speciality drugmaker Avenue Therapeutics

Most Popular

Finance

Scope gets $90 mn for expansion, procures licence for US business

Consumer

How yoga guru Ramdev-backed Patanjali Ayurved stumbled in the rush for growth

Finance

Pantomath's Bharat Value Fund raises $120 mn for mid-market deals

Finance

The colour of LP money: How desi is Indian AIF moolah?

TMT

EaseMyTrip buys 4.94% stake in B2B travel platform

People

Manipal Hospitals backer Novo Holdings ropes in former IFU exec

Google News